Heat Biologics Stock Buy Hold or Sell Recommendation

HTBX -  USA Stock  

USD 4.22  0.27  6.01%

Given the investment horizon of 90 days and your highly speculative risk level, our recommendation regarding Heat Biologics is 'Hold'. Macroaxis provides Heat Biologics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding HTBX positions. The advice algorithm takes into account all of Heat Biologics' available fundamental, technical, and predictive indicators you will find on this site.

Heat Biologics Advice 

The advice is provided from Heat Biologics' buy-and-hold perspective. Please check Heat Biologics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Heat Biologics and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Heat Biologics.

Execute Heat Biologics Buy or Sell Advice

The Heat Biologics recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Heat Biologics. Macroaxis does not own or have any residual interests in Heat Biologics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Heat Biologics' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Heat BiologicsBuy Heat Biologics


Somewhat reliableDetails

Hype Condition

Low keyDetails

Current Valuation


Odds of Distress

Very LowDetails

Economic Sensitivity

Almost neglects market trendsDetails

Analyst Consensus

Strong BuyDetails

Financial Strenth (F Score)


Financial Leverage


Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Heat Biologics has a Risk Adjusted Performance of (0.18), Jensen Alpha of (0.65), Total Risk Alpha of (0.48) and Treynor Ratio of 2.93
We provide advice to complement the regular expert consensus on Heat Biologics. Our dynamic recommendation engine utilizes a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Heat Biologics is not overpriced, please check out all Heat Biologics fundamentals, including its number of shares shorted, current ratio, current liabilities, as well as the relationship between the ebitda and beta . Given that Heat Biologics has a price to book of 0.82 X, we strongly advise you to confirm Heat Biologics market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your regular risk tolerance and investing horizon.

Heat Biologics Trading Alerts and Improvement Suggestions

Heat Biologics generated a negative expected return over the last 90 days
The company reported the previous year's revenue of 2.58 M. Net Loss for the year was (27.29 M) with loss before overhead, payroll, taxes, and interest of (9.99 M).
Heat Biologics currently holds about 132.06 M in cash with (21.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.23, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Heat Biologics has a frail financial position based on the latest SEC disclosures

Heat Biologics current analysts advice

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Heat Biologics analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Heat Biologics analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Mean Price20.67
Target Median Price19.50
Target High Price33.00
Recommendation Mean2.00
Number Of Analyst Opinions6
Target Low Price15.00
Average Consensus Strong Buy
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

Heat Biologics Returns Distribution Density

The distribution of Heat Biologics' historical returns is an attempt to chart the future uncertainty of Heat Biologics' future price movements. The chart of the probability distribution of Heat Biologics stock daily returns describes the distribution of returns around its average expected value. We use Heat Biologics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Heat Biologics returns is essential to provide solid investment advice for Heat Biologics stock.
Mean Return-0.63Value At Risk-4.4
Potential Upside3.22Standard Deviation2.55
 Return Density 
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Heat Biologics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Heat Biologics Cash Flow Accounts

201620172018201920202021 (projected)
Capital Expenditure(45.94 K)(61.38 K)(593.57 K)(155.56 K)(335.8 K)(344.64 K)
Depreciation Amortization and Accretion132.08 K134.08 K237.32 K271.62 K428.75 K462.6 K
Net Cash Flow or Change in Cash and Cash Equivalents2.9 M1.82 M12.39 M(13.11 M)1.89 M1.5 M
Issuance Purchase of Equity Shares16.74 M8.77 M40.12 M19.05 K121.45 M131.04 M
Issuance Repayment of Debt Securities2.97 M3.91 M(6.94 M)(115.2 K)(103.68 K)(106.41 K)
Net Cash Flow from Financing9.8 M8.77 M40.12 M19.05 K119.33 M128.75 M
Net Cash Flow from Investing6.61 M(530.18 K)(6.16 M)(294 K)(95.42 M)(97.93 M)
Net Cash Flow Investment Acquisitions and Disposals3.87 M6.66 M(5.57 M)(138.44 K)(95.08 M)(97.59 M)
Net Cash Flow from Operations(13.52 M)(6.4 M)(21.71 M)(12.84 M)(22.02 M)(22.6 M)
Effect of Exchange Rate Changes on Cash12.66 K(14.25 K)145.76 K(1.77 K)3.75 K3.85 K
Share Based Compensation582.63 K689.13 K788.66 K3.27 M6.38 M6.88 M

Heat Biologics Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Heat Biologics or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Heat Biologics stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Heat Biologics stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Alpha over DOW
Beta against DOW-0.22
Overall volatility
Information ratio -0.23

Heat Biologics Volatility Alert

Heat Biologics exhibits very low volatility with skewness of -0.46 and kurtosis of 2.08. However, we advise investors to further study Heat Biologics technical indicators to make sure all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Heat Biologics' stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Heat Biologics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Heat Biologics Implied Volatility

Heat Biologics' implied volatility exposes the market's sentiment of Heat Biologics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Heat Biologics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Heat Biologics stock will not fluctuate a lot when Heat Biologics' options are near their expiration.

Heat Biologics Fundamentals Vs Peers

Comparing Heat Biologics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Heat Biologics' direct or indirect competition across all of the common fundamentals between Heat Biologics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Heat Biologics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Heat Biologics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Heat Biologics by comparing valuation metrics with those of similar companies.
 Better Than Average     
 Worse Than Average Compare Heat Biologics to competition
FundamentalsHeat BiologicsPeer Average
Return On Equity(33.90) %(0.31) %
Return On Asset(18.80) %(0.14) %
Current Valuation44.37 M16.62 B
Shares Outstanding25.4 M571.82 M
Shares Owned by Insiders4.09 %10.09 %
Shares Owned by Institutions12.04 %39.21 %
Number of Shares Shorted2.34 M4.71 M
Price to Earning(1.29) X28.72 X
Price to Book0.82 X9.51 X
Price to Sales43.82 X11.42 X
Revenue2.58 M9.43 B
Gross Profit(9.99 M)27.38 B
EBITDA(27.04 M)3.9 B
Net Income(27.29 M)570.98 M
Cash and Equivalents132.06 M2.7 B
Cash per Share5.23 X5.01 X
Total Debt1.76 M5.32 B
Debt to Equity0.012 %48.70 %
Current Ratio43.95 X2.16 X
Book Value Per Share5.46 X1.93 K
Cash Flow from Operations(21.09 M)971.22 M
Short Ratio6.47 X4.00 X
Earnings Per Share(1.36) X3.12 X
Number of Employees3918.84 K
Market Capitalization113.27 M19.03 B
Total Asset11.75 M29.47 B
Retained Earnings(107.35 M)9.33 B
Working Capital6.77 M1.48 B
Current Asset11.27 M9.34 B
Current Liabilities4.5 M7.9 B
Z Score19.28.72
   Acquisition by Ostrander William L of 51487 shares of Heat Biologics subject to Rule 16b-3 [view details]

Heat Biologics Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Heat Biologics . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution18774.72
Daily Balance Of Power(0.73)
Rate Of Daily Change0.94
Day Median Price4.4
Day Typical Price4.34
Market Facilitation Index0.0
Price Action Indicator(0.32)

About Heat Biologics Buy or Sell Advice

When is the right time to buy or sell Heat Biologics? Buying financial instruments such as Heat Biologics Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Although Heat Biologics investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2018 2019 2020 2021 (projected)
Current Assets28.71 M15.21 M113.79 M122.78 M
Total Assets37.76 M25.96 M124.19 M134 M

Use Investing Ideas to Build Portfolios

In addition to having Heat Biologics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Money Funds Thematic Idea Now

Money Funds
Money Funds Theme
Funds or Etfs that invest most if their asset in companies from financial sector such as commercial banks, insurance companies, investment funds, and real estate. Money Funds theme has 40 constituents.
View All  Next Launch Money Funds
Please check Heat Biologics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Heat Biologics information on this page should be used as a complementary analysis to other Heat Biologics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Complementary Tools for Heat Biologics Stock analysis

When running Heat Biologics price analysis, check to measure Heat Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heat Biologics is operating at the current time. Most of Heat Biologics' value examination focuses on studying past and present price action to predict the probability of Heat Biologics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Heat Biologics' price. Additionally, you may evaluate how the addition of Heat Biologics to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Fundamental Analysis
View fundamental data based on most recent published financial statements
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Is Heat Biologics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Heat Biologics. If investors know Heat Biologics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Heat Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Heat Biologics is measured differently than its book value, which is the value of Heat Biologics that is recorded on the company's balance sheet. Investors also form their own opinion of Heat Biologics' value that differs from its market value or its book value, called intrinsic value, which is Heat Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Heat Biologics' market value can be influenced by many factors that don't directly affect Heat Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Heat Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine Heat Biologics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Heat Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.